Beyond Vaccine Supply: Why Location and Choice Matter

Leela Nageswaran explores how individual preferences and vaccine distribution policies can shape vaccination coverage and equity.

As measles outbreaks bring renewed attention to vaccination rates in the United States, much of the public conversation centers on whether people choose to get vaccinated. But that decision can also depend on practical considerations: Is there a convenient appointment? Is the vaccine available at a location someone trusts?

Leela Nageswaran, Associate Professor of Operations Management at the Foster School of Business, studies how these individual decisions interact with vaccine distribution policies. In a recent op-ed, she warned that changes to vaccine recommendations could lead to shortages, delays, and declining vaccination rates if policymakers overlook supply chains and patient access.

Her earlier research explored the trade-offs involved in allowing people to choose among COVID-19 vaccines. Now she’s examining real-world vaccination data from California to understand how decisions about where to distribute vaccines can affect access and equity.

We asked Nageswaran what her research reveals about the factors shaping vaccination decisions and how public health officials can use those insights to design more effective policies.

Responses have been edited for length and clarity.

What initially drew you to studying vaccination decisions, and how has your research evolved since your earlier work on COVID-19 vaccine choices?

During the COVID stay home era, vaccination was top of mind for most people. It was an ordeal to figure out when one became eligible and where to go to get a shot!

The U.S. approached this initial rollout phase mostly from an efficiency perspective: people would typically face a virtual waiting line of sorts, without knowing when they would get the shot or which vaccine they’d be assigned. I was intrigued by this “black box” approach, especially because some other countries allowed people to wait in line for a specific vaccine. This piqued my interest; having worked on modeling waiting lines and consumer behavior, it was clear that there would be trade-offs worth investigating here.

My current research looks at how the number of available doses and where they’re allocated influence vaccination decisions. For example, California adopted a policy to distribute more doses to ZIP codes deemed most disadvantaged. While this top-down approach was intended to improve equity in vaccination coverage, it doesn’t necessarily account for where people actually want to get vaccinated. We’re studying how to design allocation policies that better reflect those preferences and improve vaccination coverage and equity.

UW Foster professor Leela Nageswaran on the University of Washington campus. Her research examines vaccine distribution and vaccination access.

Getting vaccinated is a personal choice. But vaccine availability, location and individual preferences also play a role. Leela Nageswaran is studying how these factors shape vaccination rates and equity.

Vaccination research is often associated with medicine and public health. What does research conducted at a business school bring to this field, and how can it help inform public health policy and practice?

Operations managers study how people make decisions under uncertainty and how consumers behave when resources are scarce. Both resource constraints and limited information are important considerations when evaluating public health policies.

Mathematical models can help reveal unintended consequences of different policies, while data-driven models of people’s decisions allow us to quantify the effects of alternative approaches. Together, these tools help policymakers make more informed decisions.

We tend to think of vaccination as a personal choice. What does your research tell us about the other factors that influence whether someone gets vaccinated?

Personal choice is at the core of the decision to get vaccinated. But people can encounter obstacles at different stages. They may have trouble navigating conflicting information about vaccine effectiveness, questions about whom to trust, or unclear eligibility requirements. Even when they’re ready to get vaccinated, they may struggle to find a convenient appointment at the right time and location or a site offering the vaccine they want.

What kinds of preferences are you seeing when it comes to where people get vaccinated?

People are not machines – they have preferences about where they would like to get vaccinated and what type of vaccine they want.

Some may not be able to travel far from home, while others may have regular commutes to far-off places. Some may distrust large hospitals or prefer a pharmacy where they can run other errands.

We’re seeing all these preferences in our ongoing study. 

You’re now studying real-world vaccination data from California. What makes this dataset particularly valuable, and what are you hoping to learn from it?

I’m very excited about this research because it’s entirely data-driven. We obtained a comprehensive dataset on individual vaccination decisions, along with detailed information about vaccine supply assigned to different locations.

This data allows us to model people’s vaccination-site preferences and explore how different distribution strategies might improve coverage and equity. Policymakers also need to consider both where people from different neighborhoods actually got vaccinated and what types of vaccination sites they sought out.

With measles cases rising and vaccination increasingly in the public spotlight, what lessons from your research do you think are most important for public health officials and policymakers today?

I’m selfishly glad that vaccination is in the spotlight, but honestly, the best-case scenario is when it isn’t: when vaccination policies work so seamlessly that there’s nothing to report!

The through line in my work is that any policy needs to incorporate individuals’ decisions and preferences to be most successful. Removing obstacles and ensuring the right vaccine is available at the right time and location is key to achieving high coverage.

Leela Nageswaran is an Associate Professor of Operations Management and the Evert McCabe Endowed Fellow at the University of Washington Foster School of Business.